SUPERNUS PHARMACEUTICALS, INC.·4

Feb 23, 6:49 PM ET

SIEBERT JOHN M 4

4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Feb 23, 2021

Insider Transaction Report

Form 4
Period: 2021-02-19
Transactions
  • Award

    Restricted Stock Units

    2021-02-19+4,2224,222 total
    Common Stock (4,222 underlying)
  • Award

    Director Stock Option (Right to Buy)

    2021-02-19+7,3657,365 total
    Exercise: $29.61From: 2022-02-19Exp: 2031-02-19Common Stock (7,365 underlying)
Holdings
  • Common Stock

    60,953
Footnotes (2)
  • [F1]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
  • [F2]These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022.

Documents

2 files